Is C86.51 a billable ICD-10-CM code?

Yes. C86.51 is a billable, specific ICD-10-CM code and is valid for submission on a claim.

Where does C86.51 sit in the tabular list?

Neoplasms (C00-D49), in the block Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96).

C86.51

C86.51 — Angioimmunoblastic T-cell lymphoma, in remission

Billable / specific codeICD-10-CM

C86.51 is a billable, specific ICD-10-CM code for angioimmunoblastic t-cell lymphoma, in remission. It is valid for submission on a claim.

Inclusion terms

Alternative wordings a physician may use in the chart for this same code.

Angioimmunoblastic lymphadenopathy with dysproteinemia (AILD), in remission

Risk adjustment

C86.51 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:

HCC 19 Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers1.798 RAF

Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.

Medicare coverage

C86.51 is named in 31 Medicare coverage policies — 31 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.

A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
A52479Oral Anticancer Drugs - Policy Article
A52479Oral Anticancer Drugs - Policy Article
A52479Oral Anticancer Drugs - Policy Article

Related codes at this level

Codes that share C86.5. If C86.51 is not quite right, the correct code is usually one of these.

C86.50Angioimmunoblastic T-cell lymphoma not having achieved remission

Questions about C86.51

Is C86.51 a billable ICD-10-CM code?: Yes. C86.51 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
Where does C86.51 sit in the tabular list?: Neoplasms (C00-D49), in the block Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96).